Volume 26, Issue 5 (September-October 2021)

OPINION ARTICLE

5G and human health
Kiki Theodorou, Charis Tyrakis, Vasiliki Softa, Constantin Kappas; pp 1698-1708 (Pubmed Abstract, PDF)

SPECIAL ARTICLES

Cigarette smoking and medical students
Željana Prijić, Rajko Igić; pp 1709-1718 (Pubmed Abstract, PDF)

Impact of SARS-CoV-2 infection on oral carcinoma patients
Vasileios Ragos, Maria Adamopoulou, Arezina Manoli, Spyros Katsinis, Sotirios Papouliakos, Odysseas Dimas, Evangelos Tsiambas, Dimitrios Roukas, George Papanastasiou, Despoina Spyropoulou, Loukas Manaios, Asimakis Asimakopoulos, Nicholaos Mastronikolis, Fragiski Anthouli-Anagnostopoulou; pp 1719-1722 (Pubmed Abstract, PDF)

REVIEW ARTICLES

Basic principles of molecular biology of cancer cell-Molecular cancer indicators
Emmanuel N. Kontomanolis, Antonios Koutras, Athanasios Syllaios, Dimitrios Schizas, Sofia Kalagasidou, Athanasios Pagkalos, Dimitra Alatzidou, Pelagia Kantari, Thomas Ntounis, Zacharias Fasoulakis; pp 1723-1734 (Pubmed Abstract, PDF)

Diagnosis, treatment and quality of life in patients with cancer-related lymphedema
Ioannis Kalemikerakis, Agoritsa Evaggelakou, Anna Kavga, Maria Vastardi, Theocharis Konstantinidis, Ourania Govina; pp 1735-1741 (Pubmed Abstract, PDF)

The surgical challenge of oligometastatic pancreatic cancer: A systemic review of the literature.
Gregory Christodoulidis, Dimitrios E. Magouliotis,  Athina A. Samara, Theodoros Floros, Prokopis-Andreas Zotos, Maria Tolia, Dimitris Zacharoulis; pp 1742-1746 (Pubmed Abstract, PDF)

Chyle leak after major pancreatic surgery. Is this an underestimated complication? A narrative review of the literature
Michail Vailas, Maria Sotiropoulou, Nikolaos Benetatos, Francesk Mulita, Ioannis Maroulis, Stylianos Germanos; pp 1747-1753 (Pubmed Abstract, PDF)

ORIGINAL ARTICLES

GYNECOLOGIC CANCERS

Ovarian cancer: 20-year experience with cytoreductive surgery and perioperative intraperitoneal chemotherapy
Konstantinos Ntatsis, Evangelia Papantoni, Dimitrios Kyziridis, Apostolos Kalakonas, Christos Hristakis, Chara Tzavara, Antonios-Apostolos Tentes; pp 1754-1761 (Pubmed Abstract, PDF)

Obesity is a predictive biomarker of poor benefit from single-agent bevacizumab therapy in recurrent ovarian cancer patients
Hiroyuki Yoshida, Daisuke Shintani, Keiichi Fujiwara; pp 1762-1767 (Pubmed Abstract, PDF)

miR-34a-5p blocks cervical cancer growth and migration by downregulating CDC25A
Tao Jiang, Hongyan Cheng; pp 1768-1774 (Pubmed Abstract, PDF)

Dilatation and curettage in endometrial cancer. What is the correlation with hysterectomy histology? A 14 years retrospective cohort study
Anastasios Liberis, Evangelia Mareti, Georgios Pratilas, Stamatios Petousis, Angelos Daniilidis, Anastasia Vatopoulou, Konstantinos Pantazis, Fotios Chatzinikolaou, Dimosthenis Miliaras, Konstantinos Dinas ; pp 1775-1781 (Pubmed Abstract, PDF)

miR-99a inhibits proliferation and migration of cervical cancer cells by targeting IGF1R
Li Han; pp 1782-1788 (Pubmed Abstract, PDF)

Effects of GATA6-AS/MMP9 on malignant progression of endometrial carcinoma
Yimei Zhao, Xiuzhen Zou, Guohua Wang, Yingying Liu, Chenying Zhang, Wei Lu, Qingtao Li; pp 1789-1795 (Pubmed Abstract, PDF)

Efficacy of laparoscopic, pelvic and para-aortic lymphadenectomy in the treatment of endometrial carcinoma
Hongmei Wang, Wenying Li, Naimei Li; pp 1796-1801 (Pubmed Abstract, PDF)

Application value of Doppler ultrasound combined with CA125 and CA19.9 in the early diagnosis of epithelial ovarian cancer
Yanfang Cui, Shaohua Shi, Shaoqin Zhang, Chunyan Huang, Peng Li, Chao Han; pp 1802-1808 (Pubmed Abstract, PDF)

Clinical significance of Keap1 in cervical cancer
Jing Wang, Xin Li, Yun Zhou, Li Hong; pp 1809-1814 (Pubmed Abstract, PDF)

LUNG CANCER

Joint prediction of solitary pulmonary module malignant probabilitybased on logistic regression and malignant tendency comprehensive score
Shutong Zhou, Qun Wang, Tianyu Tang, Meizhu Cao, Yan Tan, Kaixian Bai, Wenjun Liu; pp 1815-1823 (Pubmed Abstract, PDF)

A cross-sectional study for assessing perceived symptoms, depression and quality of life in advanced lung cancer patients 
Maria Lavdaniti, Konstantina Patrikou, Paraskevi-Maria Prapa, Maria Vastardi,  Evangelos C Fradelos, Ioanna V. Papathanasiou,  Foteini Tzavella, Victoria Alikari, George Tzavelas; pp 1824-1831 (Pubmed Abstract, PDF)

BMSCs-Derived Exosomal MiR-126-3p Inhibits the Viability of NSCLC Cells by Targeting PTPN9
Jun Chen, Xianzhou Yang, Cheng Ding, Jun Zhao; pp 1831-1841 (Pubmed Abstract, PDF)

Trefoil factor 3 silencing can inhibit the proliferation and apoptosis of lung cancer cells
Moran Liu, Yin Xiao; pp 1842-1849 (Pubmed Abstract, PDF)

Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis
Yanping Xu, Rongping Zhao, Hua Wang, Jianwei Jiang, Zhenwei Wang, Jiayuan Wang, Wei Zhang, Min Li; pp 1850-1861 (Pubmed Abstract, PDF)

Characteristics of pathogenic microbes in lung microenvironment of lung cancer patients without respiratory infection
Miao Zhang, Yan Zhang, Yaguang Han, Xin Zhao, Yi Sun; pp 1862-1870 (Pubmed Abstract, PDF)

EPHA5 Enhances the Stemness of Non-small cell lung cancer Cells Through Activating the Wnt Signaling Pathway
Jie Li, Yehan Zhu; pp 1871-1878 (Pubmed Abstract, PDF)

Clinical analysis of 125I seed implantation combined with epidermal growth factor receptor-tyrosine kinase inhibitors in advanced non-small cell lung cancer
Xiaoshan Wang, Dong Wang; pp 1879-1886 (Pubmed Abstract, PDF)

COLORECTAL CANCER

The association between post-progression survival and clinical characteristics of patients with metastatic colon cancer: A single center experience
Mehmet Engin Ozekin, Ali Gokyer, Ahmet Kucukarda, Osman Kostek, Kubilay Issever, Bulent Erdogan; pp 1887-1892 (Pubmed Abstract, PDF)

Impact of peroxiredoxin-6 expression on colon adenocarcinoma
Evangelos Falidas, Eirini Kitsiouli, Dimitrios Tsounis, Asimina Kalogirou, Evangelos Tsiambas, George Tsouvelas, Stylianos Papadopoulos, Michail Mitsis, Marilena Lekka, Konstantinos Vlachos; pp 1893-1897 (Pubmed Abstract, PDF)

Fatty acid in colorectal cancer in adult and aged patients of both sexes
Jovan T. Juloski, Tamara Popovic, Jasmina Debeljak Martacic, Vladica V. Cuk, Marija S. Milic Perovic, Marija S. Stankovic, Alexander M. Trbovich, Silvio R. De Luka; pp 1898-1907(Pubmed Abstract, PDF)

Prognostic significance of primary tumor localization in patients with metastatic colorectal cancer: Is it beneficial to select targeted treatment? Real-life experience from Turkey
Burcin Cakan, Ozgur Acikgoz, Ahmet Bilici, Tarik Demir, Bala Basak Oven, Jamshid Hamdard, Oktay Olmuscelik, Omer Fatih Olmez, Mesut Seker, Ozcan Yildiz; pp 1908-1917 (Pubmed Abstract, PDF)

Efficacy of endoscopic submucosal dissection in treating early colorectal cancer and precancerous lesions
Lianlian Qu, Yifeng Cheng; pp 1919-1924 (Pubmed Abstract, PDF)

RNF6 enhances radioresistance in colorectal cancer via activating the Wnt pathway
Xi Zhong, Bin Zhou, Zhaoying Lv, Yong Liu; pp 1925-1930 (Pubmed Abstract, PDF)

Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer
Shujia Chen, Xiaofei Li, Lianyi Guo, Jiachen Zhang, Li Li, Xueqiu Wang, Yinghui Zhu, Jiwei Wang; pp 1931-1941 (Pubmed Abstract, PDF) (Supplementary materials)

LIVER CANCER

HOXD10 expression as a prognostic factor for hepatocellular carcinoma treated with curative resection
Sujin Park, Sangjoon Choi, Hyun Hee Koh, Cheol- Keun Park, Sang Yun Ha; pp 1942-1949 (Pubmed Abstract, PDF)

Comparing the efficacy and safety of local-regional treatments forhepatocellular carcinoma with portal/hepatic vein tumor thrombosis in China: a network meta-analysis of randomized controlled trials
Qi-Qiao Wu, Hong Gao, Shi-Suo Du, Yi-Xing Chen, Yong Hu, Ping Yang, Jia-Zhou Hou, Zhao-Chong Zeng; pp 1950-1957 (Pubmed Abstract, PDF)

The Akt/GSK3β/β-catenin signaling regulated by ZCCHC14 is responsible for accelerating the proliferation of hepatocellular carcinoma
Yujun Cui, Jijun Zhang, Chiyi Chen, Jinxuan Luo, Hao Yan, Wentao Jiang; pp 1958-1963 (Pubmed Abstract, PDF)

LINC00355 triggers malignant progression of hepatocellular carcinoma via the sponge effect on miR-217-5p with the involvement of the Wnt/β-catenin signaling
Xuanming Luo, Miyesaier A.Budureyimu, Guohuan Yang, Zhe Yan, Xiutao Fu, Pinxiang Lu, Dexiang Zhang, Shulong Zhang, Zhenbin Ding; pp 1964-1969 (Pubmed Abstract, PDF)

BREAST CANCER

Feasibility of oncoplastic surgery in breast cancer patients with associated in situ carcinoma
Alexandra Caziuc, David Andras, Vlad Fagarasan, George-Calin Dindelegan; pp 1970-1974 (Pubmed Abstract, PDF)

The landscape of angiogenesis subtypes for breast cancer: a comprehensive analysis based on the Cancer Genome Atlas
Xiao-fei Peng, Fang-lu Qin, Wen-jie Chen, Han Zhang, Zi-yue Mai, Jian Zeng; pp 1975-1990 (Pubmed Abstract, PDF)

Comparative analysis of clinicopathologic characteristics and molecular subtypes of invasive papillary carcinoma of the breast and invasive ductal carcinoma: results from SEER database
Shujie Chen, Jie Wang, Li Yang, Min Ji, Sheng Chen; pp 1991-2002 (Pubmed Abstract, PDF)

HEAD & NECK CANCER

Treatment effect of concurrent chemoradiotherapy after surgery and its effect on postoperative swallowing function of patients with locally advanced hypopharyngeal carcinoma 
Xiaoxu Wang, Liuzhong Wang, Ling Gao, Xiao Guo, Hua Cao; pp 2003-2009 (Pubmed Abstract, PDF)

Oral mucositis-related neuropathic pain in head and neck cancer patients receiving radiotherapy or chemo-radiotherapy. A prospective study.
Maria Kouri, Ourania Nicolatou-Galitis, Athina Vadalouca, Vassilis Kouloulias, Erofili Papadopoulou, Emmanouil Vardas, Euthimios Kyrodimos, Miltiadis Trichas, Anna Zygogianni, Zoi Liakouli, Evangelos Galitis, Ioanna Siafaka, Andromachi Kougioumtzopoulou, Amanda Psyrri; pp 2010-2018 (Pubmed Abstract, PDF)

Meta-analysis on the safety and efficacy of early oral feeding after total laryngectomy
Xuelian Yi, Chunhong Hu, Yi Peng, Zili Wen, Xue Li, Linlin Ye, Qingsong Huang; pp 2019-2025 (Pubmed Abstract, PDF)

HEMATOLOGIC MALIGNANCIES

Combination of Venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia: A case series from a single center
Sema Secilmis, Mehmet Sinan Dal, Merih Kizil Cakar, Alparslan Merdin, Nuran Ahu Baysal, Fevzi Altuntas; 2026-2032 (Pubmed Abstract, PDF)

Regulatory effects of miR-188-5p/XRCC5 on the progression of natural killer/T-cell lymphoma
Qianqian Huang, Siruiyun Ding, Hui Zhang; pp 2033-2039 (Pubmed Abstract, PDF)

Integrated analysis of hub gene expression in multiple myeloma
Yanping Huang, Jinxiong Huang, Peng Zhang, Jun Luo, Peng Cheng, Liu Miao, Yongrong Lai; pp 2040-2052 (Pubmed Abstract, PDF)

KIDNEY CANCER

Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types

Xiaoqiang Wang, Weihui Kong, Yanhui Wang, Yuhong Wang, Yueqin Chen, Zhitao Shi, Yanjie Liu; 2053-2058 (Pubmed Abstract, PDF)

Expression of miR-410 in peripheral blood of patients with clear cell renal cell carcinoma and its effect on proliferation and invasion of Caki-2 cells
Zhi Liu, Jun Zhang, Xuechun Hu, Qingyu Ge, Jun Xiao, Chrismis Novalinda Ginting; pp 2059-2066 (Pubmed Abstract, PDF)

Efficacy analyses of axitinib and nivolumab in metastatic renal cell carcinoma after failure of targeted therapy: which is better?
Oktay Halit Aktepe, Fadime Sinem Ardic, Deniz Yuce, Deniz Can Guven, Gurkan Guner, Hasan Cagri Yildirim, Saadettin Kilickap, Alev Turker, Neyran Kertmen, Serkan Akin, Sercan Aksoy, Omer Dizdar, Suayib Yalcin, Mustafa Erman; pp 2067-2073 (Pubmed Abstract, PDF)

CNS TUMORS

Serpin peptidase inhibitor, clade E nexin group 1 promotes cellular proliferative capacities and malignant behaviors in glioblastomathrough upregulating hairy and enhancer of split-1
Tao Ma, Kai Qian, Tuoye Xu, Xi Wang, Tengda Qian, Jing Shi, Lixin Li; pp 2074-2083 (Pubmed Abstract, PDF)

DDX46 accelerates the proliferation of glioblastoma by activating the MAPK-p38 signaling
Ji Ma, Zhenying Gao, Xueni Liu; pp 2084-2089 (Pubmed Abstract, PDF)

OSTEOSARCOMA

FAT10 stimulates the development of osteosarcoma by regulating the JAK/STAT signaling pathway
Faliang Shi, Longyun Li, Yongjie Cheng; pp 2090-2096 (Pubmed Abstract, PDF)

Development and validation of a nomogram for specific survival in osteosarcoma patients less than 60 years old: a population-based study
Jun Zhao, Jianfei Jiao, Yu Su, Long Mu; pp 2097-2105 (Pubmed Abstract, PDF)

PROSTATE CANCER

The evaluation of sexual functions of prostate cancer patients receiving radiotherapy
Yasemin Guzle Adas, Esra Kekilli, Muzaffer Bedri Altundag; pp 2106-2110 (Pubmed Abstract, PDF)

BTBD7 accelerates the epithelial-mesenchymal transition, proliferation and invasion of prostate cancer cells
Bin Chen, Chang Liu, Guohui Bai, Yuhang Zhu, Houqiang Xu; pp 2111-2116 (Pubmed Abstract, PDF)

BLADDER CANCER

Relationship between survival outcomes and microsatellite instability, tumor infiltrating lymphocytes and programmed cell death ligand-1 expression in patients with bladder cancer and radical cystectomy
Deniz Tural, Emre Akar, Halil Firat Baytekin, Didem Canoglu, Mesut Yilmaz, Volkan Tugcu; pp 2117-2125 (Pubmed Abstract, PDF)

ESOPHAGEAL CANCER

Stereotactic radiosurgery for the treatment of esophageal carcinoma brain metastases
Chutian Zheng, Yuxiang Weng, Qingsheng Xu; pp 2126-2130 (Pubmed Abstract, PDF)

GASTRIC CANCER

Dynamic perspective of the neutrophil-to-lymphocyte ratio in metastatic gastric cancer
Antia Cousillas Castineiras, Elena Gallardo Martin, Ana Fernandez Montes, Marta Carmona Campos, Marta Covela Rua, Mercedes Salgado Fernandez, María Luz Pellon Augusto, Nieves Martínez Lago, Yolanda Vidal Insua, Elena Brozos Vazquez, Juan De La Camara, Ana Alonso Herrero, Jose Carlos Mendez Mendez; pp 2131-2140 (Pubmed Abstract, PDF)

MELANOMA

Application of dermal regenerative template in reconstructing skin defects after plantar malignant melanoma excision
Xuanlong Zhang, Yute Sun, Zuoqiong Hou, Binlin Luo, Chujun Li, Keyu Jiang, Jinfang Liu, Gang Yao, Jian Tang; pp 2141-2148 (Pubmed Abstract, PDF)

PANCREATIC CANCER

MicroRNA-204-3p inhibits metastasis of pancreatic cancer via downregulating MGAT1
Wei Liu, Xinglei Li, Xiao Tan, Xing Huang, Bole Tian; pp 2149-2156 (Pubmed Abstract, PDF)

THYROID CANCER

The relationship between types of inflammatory cells located at the micro-environment of papillary thyroid microcarcinoma prognostic factors
Sirin Kucuk, Pembe Oltulu; pp 2157-2168 (Pubmed Abstract, PDF)

MISCELLANEOUS

The effect of adjuvant chemotherapy on the survival of patients with high-risk soft tissue sarcomas: Single center experience
Ermrah Eraslan, Aysegul Ilhan Gulesen, Fatih Yildiz, Gulnihal Tufan, Ulku Yalcintas Arslan, Necati Alkis; pp 2169-2175 (Pubmed Abstract, PDF)

Assessment of oncology patients’ satisfaction from intravenous chemotherapy 
Christos Stylianou, Ioannis Kalemikerakis, Maria Vastardi, Anna Kavga, Nikoletta Margari, Eleni Dokoutsidou, Theocharis Konstantinidis, Ourania Govina; pp 2176-2182 (Pubmed Abstract, PDF)

COVID-19 vaccines and cancer patients: acceptance, attitudes and safety
Gorana Matovina Brko, Maja Popovic, Masa Jovic, Jelena Radic, Milka Bodlovic Kladar, Ivan Nikolic, Vladimir Vidovic, Ivana Kolarov Bjelobrk, Biljana Kukic, Svetlana Salma, Jelena Litavski, Nemanja Petrovic, Bojana Vranjkovic, Tatjana Roganovic, Maja Ruzic, Tihomir Dugandzija, Lazar Popovic; pp 2183-2190 (Pubmed Abstract, PDF)

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy in the treatment of rare tumors with peritoneal metastases
Dimitrios Tsolakidis, Dimitrios Kyziridis, Apostolos Kalakonas, Anastasios Limberis, Christos Hristakis1, Antonios-Apostolos Tentes; pp 2191-2195 (Pubmed Abstract, PDF)

Is early change in systemic inflammatory markers associated with treatment response in patients who received pazopanib?
Bulent Erdogan, Osman Kostek, Muhammet Bekir Hacioglu, Ali Gokyer, Ahmet Kucukarda, Erkan Ozcan, Ivo Gokmen, Sernaz Uzunoglu, Irfan Cicin; pp 2196-2201 (Pubmed Abstract, PDF)

LETTERS TO THE EDITOR

Some subgroups might get less benefit from adjuvant olaparib trial in high-risk, HER2-negative and germline BRCA2 BRCA1- or BRCA2-mutated early breast cancer patients
Kadri Altundag; p 2202 (Pubmed Abstract, PDF)

Association between aspirin use and reduction in risk of triple negative breast cancer: Still debatable issue?
Kadri Altundag; pp 2202-2203 (Pubmed Abstract, PDF)

Vismodegib and radiotherapy combination in treatment of cancer
Yasemin Benderli Cihan; pp 2203-2204 (Pubmed Abstract, PDF)

Is there any association between human papillomavirus amplification and ductal histology in invasive breast carcinoma?
Kadri Altundag; p 2204 (Pubmed Abstract, PDF)

Association between breast cancer risk factors and tumor subtypes
Kadri Altundag; pp 2204-2205 (Pubmed Abstract, PDF)

The place of Omalizumab in the treatment of Carboplatin hypersensitivity
Yasemin Benderli Cihan; pp 2205-2206 (Pubmed Abstract, PDF)

Taxane use for breast cancer-related lymphoedema risk
Kadri Altundag; p 2206 (Pubmed Abstract, PDF)

Preference of trastuzumab emtansine as a second or third-line treatment in patients with human epidermal growth factor receptor 2 positive metastatic breast cancer refractory to trastuzumab and pertuzumab
Kadri Altundag; pp 2206-2207 (Pubmed Abstract, PDF)

SARS-CoV-2 influence on renal cell carcinoma patients
Maria Adamopoulou, Loukas Manaios, Sotirios Papouliakos, Evangelos Tsiambas; pp 2207-2208 (Pubmed Abstract, PDF)

Some concerns about clinical-pathological characteristics of breast cancer cases detected by chest computed tomography
Kadri Altundag; p 2208 (Pubmed Abstract, PDF)

Reset link sent!

Link for password reset has been emailed to you. Please check your email.